Endothelin-1 receptor subtypes expression and binding in a perfused rat model of myocardial infarction

Comparative Biochemistry and Physiology - C Toxicology and Pharmacology

Volumn 134, Issue 1, 2003, Pages 35-43

  Bikhazi, Anwar B ^a   Khalifeh, Adeeb M ^b   Jaroudi, Wael A ^a   Saadeddine, Rihab E ^a   Jurjus, Abdu R ^a   El Sabban, Marwan E ^a   Bitar, Khalil M ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b NONE

Author keywords

Endothelin 1; Heart; Hypertrophy; Mitogenesis; Receptor regulation

Indexed keywords

3 [(3 CHOLAMIDOPROPYL)DIMETHYLAMMONIO] 1 PROPANESULFONIC ACID; BIOCHEMICAL MARKER; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; LIGAND; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY ENDOTHELIUM; ARTICLE; BINDING AFFINITY; CELL SPECIFICITY; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE MODEL; EFFLUENT; FLUORESCENCE; HEART INFARCTION; HEART MUSCLE CELL; HEART PERFUSION; HEART RIGHT ATRIUM; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HORMONE ACTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIGAND BINDING; MALE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RECEPTOR BINDING; REGULATORY MECHANISM; UPREGULATION; WESTERN BLOTTING;

ANIMALIA;

EID: 0347296319     PISSN: 15320456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1532-0456(02)00209-0     Document Type: Article

References (16)

1. Depuis J., Rouleau J.L., Cernacek P. Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction. Circulation. 98:1998;1684-1687.
2. El-Sabban M.E., Hassan K.A., Birbari A.E., Bitar K.M., Bikhazi A.B. Angiotensin II binding and extracellular matrix remodeling in a rat model of myocardial infarction. Journal of the Renin-Angiotensin-Aldosterone System. 1:(4):2000;369-378.
3. Frelin C., Guedin D. Why are circulating concentration of endothelin-1 so low? Circ. Res. 28:1994;1613-1622.
4. Goresky C.A., Bach G.G., Cousineau D., et al. Handling of tracer norepinephrine by the dog liver. Am. J. Physiol. 256:1989;G107-G123.
5. 125I-insulin on capillary endothelial and myocyte cell membranes in normal and streptozotocin-induced diabetic perfused rat hearts. Comp. Biochem. Physiol. A. 117:1997;523-530.
6. Hayasaki Y., Nakajima M., Kitano Y., Iwasaki T., Shimamura T., Iwaki K. ICAM-1 expression on cardiac myocytes and aortic endothelial cells via their specific endothelin receptor subtype. Biochem. Biophys. Res. Commun. 229:1996;817-824.
7. Kobayshi T., Miyauchi T., Sakai S., et al. Downregulation of ET(B) receptor, but not ET(A) receptor, in congestive lung secondary to heart failure. Are marked increases in circulating endothelin-1 partly attributable to decreases in lung ET(B) receptor-mediated clearance of endothelin-1? Life Sci. 62:1998;185-193.
8. Kusumoto K., Awane Y., Fujiwara S., Watanabe T. Role of endogenous endothelin in the extension of rabbit myocardial infarction. J. Cardiovasc. Pharmacol. 22:1993;S339-S342.
9. Nguyen Q.T., Cernacek P., Calderoni A., et al. Endothelin A receptor blockade causes adverse left ventricular remodeling, improves pulmonary artery pressure after infarction in the rat. Circulation. 98:1998;2323-2330.
10. Pfeffer J.M., Finn P.V., Zornoff L.A., Pfeffer M.A. Endothelin-A receptor antagonism during acute myocardial infarction in a rat model. Cardiovasc. Drugs Ther. 14:2000;579-587.
11. Ray S.G., McMurray J.J., Morton J.J., Dargie H.J. Circulating endothelin in acute ischemic syndromes. Br. Heart J. 67:1992;383-386.
12. Russell F.D., Molenaar P. The human heart endothelin system: ET-1 synthesis, storage, release and effect. Trends Pharmacol. Sci. 21:2000;353-359.
13. Serneri G.G.N., Cecioni I., Vanni S., et al. Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy. Circ. Res. 86:2000;377-385.
14. Simonson M.S., Dunn M.J. Cellular signaling by peptides on the endothelin gene family. Fed. Am. Soc. Exp. Biol. J. 4:1990;2989-3000.
15. Spieker L.E., Noll G., Ruschitzka F.T., Luscher T.F. Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future? J. Am. Coll. Cardiol. 37:2001;1493-1505.
16. Stjernquist M. Endothelin-vasoactive peptide and growth factors. Cell. Tissue. Res. 292:1998;1-9.